Creative Medical Technology Holdings, Inc. - Common Stock (CELZ)
3.9800
-0.2500 (-5.91%)
Creative Medical Technology Holdings Inc is a biotechnology company focused on the development of innovative medical therapies and treatments, particularly in the fields of regenerative medicine and cellular therapies
The company aims to transform healthcare through research and development of novel procedures and products that harness the body’s natural healing mechanisms. By leveraging advancements in cell-based treatments, Creative Medical Technology Holdings seeks to address a variety of medical conditions, providing solutions that enhance patient outcomes and quality of life. Through its commitment to scientific innovation, the company is dedicated to pioneering breakthroughs in medical technology.
Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes.
Creative Medical Technology Holdings, Inc. (NASDAQCELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.
Gainers Avalo Therapeutics, Inc. (NASDAQAVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800 series.
